Literature DB >> 21429608

Locoregional and distant failure following image-guided stereotactic body radiation for early-stage primary lung cancer.

Sameer K Nath1, Ajay P Sandhu, Daniel Kim, Anjali Bharne, Polly D Nobiensky, Joshua D Lawson, Mark Fuster, Lyudmila Bazhenova, William Y Song, Arno J Mundt.   

Abstract

PURPOSE: To report our institutional experience using image-guided stereotactic body radiation therapy (SBRT) for early stage lung cancer, including an analysis into factors associated with nodal and distant failures (NF, DF).
METHODS: Forty-eight patients with early-stage primary lung cancer were treated with image-guided SBRT between 2007 and 2009. Median prescription dose was 48 Gy in 4 fractions. Toxicity was graded according to the NCI CTCAE v3.0 scale.
RESULTS: Local failure was detected in two lesions and actuarial 24-month local control was 95%. At 24 months, the cumulative incidence of NF was 6%, and DF was 29%. Larger lesions (>3 cm) and younger age (<70 years) were the only factors found to be significantly correlated with increased DF (p=0.005 and p=0.015, respectively). A single grade ≥ 3 toxicity was observed. After adjusting for age and lesion size, distant failure was significantly associated with a poorer OS (Cox regression, p=0.0059).
CONCLUSION: Image-guided SBRT can produce excellent LC rates with minimal toxicity. Distant failure was a major determinant of OS and the most common pattern of failure, indicating a potential role for systemic therapy in younger patients with large lesions.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21429608     DOI: 10.1016/j.radonc.2011.02.006

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  17 in total

1.  Effects of the recurrence pattern on patient survival following SABR for stage I lung cancer.

Authors:  Elisabeth Weiss; Xiaoyan Deng; Nitai Mukhopadhyay; Nuzhat Jan
Journal:  Acta Oncol       Date:  2020-01-12       Impact factor: 4.089

2.  A pilot study using kernelled support tensor machine for distant failure prediction in lung SBRT.

Authors:  Shulong Li; Ning Yang; Bin Li; Zhiguo Zhou; Hongxia Hao; Michael R Folkert; Puneeth Iyengar; Kenneth Westover; Hak Choy; Robert Timmerman; Steve Jiang; Jing Wang
Journal:  Med Image Anal       Date:  2018-09-15       Impact factor: 8.545

Review 3.  Tumor control probability modeling for stereotactic body radiation therapy of early-stage lung cancer using multiple bio-physical models.

Authors:  Feng Liu; An Tai; Percy Lee; Tithi Biswas; George X Ding; Isaam El Naqa; Jimm Grimm; Andrew Jackson; Feng-Ming Spring Kong; Tamara LaCouture; Billy Loo; Moyed Miften; Timothy Solberg; X Allen Li
Journal:  Radiother Oncol       Date:  2016-11-18       Impact factor: 6.280

4.  Stereotactic Body Radiotherapy for Early-stage Non-small-cell Lung Cancer in Patients 80 Years and Older: A Multi-center Analysis.

Authors:  Richard J Cassidy; Pretesh R Patel; Xinyan Zhang; Robert H Press; Jeffrey M Switchenko; Rathi N Pillai; Taofeek K Owonikoko; Suresh S Ramalingam; Felix G Fernandez; Seth D Force; Walter J Curran; Kristin A Higgins
Journal:  Clin Lung Cancer       Date:  2017-03-16       Impact factor: 4.785

Review 5.  Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating meta-analysis.

Authors:  Alexander Chi; Haiquan Chen; Sijin Wen; Haijuan Yan; Zhongxing Liao
Journal:  Radiother Oncol       Date:  2017-05-22       Impact factor: 6.280

Review 6.  SBRT in operable early stage lung cancer patients.

Authors:  Johannes Roesch; Nicolaus Andratschke; Matthias Guckenberger
Journal:  Transl Lung Cancer Res       Date:  2014-08

7.  Positron-emission tomography CT to identify local recurrence in stage I lung cancer patients 1 year after stereotactic body radiation therapy.

Authors:  M Essler; J Wantke; B Mayer; K Scheidhauer; R A Bundschuh; B Haller; S T Astner; M Molls; N Andratschke
Journal:  Strahlenther Onkol       Date:  2013-04-24       Impact factor: 3.621

Review 8.  Stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC): contemporary insights and advances.

Authors:  Nikhil T Sebastian; Meng Xu-Welliver; Terence M Williams
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

9.  Pretreatment identification of micro-metastasis in mediastinal lymph node by endobronchial ultrasound-guided transbronchial needle aspiration for early-stage non-small cell lung cancer-is it time yet?

Authors:  Abhishek Biswas; Michael A Jantz; Hiren J Mehta
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

10.  Clinical outcomes following image-guided stereotactic body radiation for pulmonary oligometastases.

Authors:  Daniel Kim; Mark M Fuster; Sameer K Nath; Anjali Bharne; William Read; Lyudmilla Bazhenova; William Y Song; Arno J Mundt; Ajay P Sandhu
Journal:  J Radiosurg SBRT       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.